Apyx Medical (APYX) Accumulated Expenses (2010 - 2026)

Apyx Medical's Accumulated Expenses history runs 17 years deep, the most recent figure standing at $6.4 million for Q1 2026.

• Quarterly Accumulated Expenses fell 6.65% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (down 6.65% YoY) and the FY2025 annual result came in at $8.2 million, up 5.97% from the prior year.
• Accumulated Expenses was $6.4 million for Q1 2026 at Apyx Medical, down from $8.2 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $9.7 million in Q4 2023 and bottomed at $6.4 million in Q1 2026.
• A 5-year average of $7.9 million and a median of $7.9 million in 2023 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses rose 24.64% — and 2024, when it slipped 19.77%.
• Apyx Medical's Accumulated Expenses stood at $8.9 million in 2022, then rose by 8.21% to $9.7 million in 2023, then decreased by 19.77% to $7.8 million in 2024, then gained by 5.97% to $8.2 million in 2025, then retreated by 22.36% to $6.4 million in 2026.
• Business Quant data shows APYX's Accumulated Expenses at $6.4 million in Q1 2026, $8.2 million in Q4 2025, and $7.3 million in Q3 2025.